AzTrials
AzTrials

FibromyalgiaNCT07830186

Qigong Intervention for Fibromyalgia

A study testing Mobility-Intensive Qigong Exercise and Static Posture-Based Qigong Exercise in people with Fibromyalgia, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized controlled pilot study investigates the comparative efficacy of mobility-intensive Qigong exercises versus static posture-based Qigong exercises in patients diagnosed with fibromyalgia. Read more about this study

Who is it for?
Ages 30 to 50 years, women only
Conditions the study is for
Fibromyalgia
What is being tested?
Mobility-Intensive Qigong Exercise and Static Posture-Based Qigong Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Oct 2026to 21 Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 50 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Female patients aged between 30 and 50 years.
  • Diagnosed with fibromyalgia according to the 2010 American College of Rheumatology (ACR) criteria.
  • Non-obese, defined as Body Mass Index (BMI) < 30 kg/m².
  • Lack of clinical improvement despite receiving pharmacological treatment for more than 3 months.
  • Willingness to adhere to the 12-week supervised online exercise program.

Who cannot join

  • Pregnancy or currently breastfeeding.
  • Presence of advanced musculoskeletal pathologies (e.g., inflammatory arthritis, severe osteoarthritis).
  • Diagnosed neurological disorders or peripheral neuropathy.
  • Known severe cardiovascular diseases.
  • History of surgical intervention within the past 4 months.
  • Participation in any regular physical exercise or rehabilitation program within the past 2 months prior to enrollment.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

MERYEM AKSARI GEDİKLİ, PT, MSc, PhD(c) contact

+90 531 208 15 15

aksarimeryem@gmail.com

Turkey (Türkiye)1 site
  • Akdeniz University Hospital, Department of Physical Medicine and Rehabilitation

    Antalya, 07070

    Meryem Aksarı Gedikli, PT, MSc, PhD(c), +90 531 208 15 15, aksarimeryem@gmail.com

Other trials in Turkey (Türkiye)

About this study

Official title: Qigong Intervention for Fibromyalgia: Improving Spinal Mobility in Fibromyalgia Patients: A Randomized Controlled Pilot Study

This randomized controlled pilot study investigates the comparative efficacy of mobility-intensive Qigong exercises versus static posture-based Qigong exercises in patients diagnosed with fibromyalgia. Participants are randomly allocated to either a mobility-intensive Qigong intervention group or a static posture-based Qigong intervention group. The primary objectives are to evaluate improvements in spinal mobility and reductions in pain levels. Secondary outcomes include enhancements in functional exercise capacity, reductions in fatigue severity, and improvements in health-related quality of life. All outcome assessments are conducted at baseline and upon completion of the intervention program.

Read the detailed description

Study Rationale and Design:

Fibromyalgia is a chronic musculoskeletal condition characterized by widespread pain, debilitating fatigue, and reduced physical functioning, frequently accompanied by marked limitations in spinal mobility. Mind-body movement modalities such as Qigong demonstrate potential in fibromyalgia rehabilitation; however, comparative evidence elucidating the specific efficacy of dynamic mobility-oriented movement sets versus static posture-based regimens remains sparse.

This study is designed as a double-blind (participants and outcome assessors), two-arm randomized controlled pilot trial. A total of 36 female participants meeting the 2010 American College of Rheumatology (ACR) diagnostic criteria are allocated in a 1:1 ratio using computer-generated simple randomization to one of two active interventions: Mobility-Intensive Qigong (Group 1) or Static Posture-Based Qigong (Group 2). Participants are informed that the trial compares two gentle therapeutic exercise programs to maintain participant blinding, while data analysts and outcome assessors remain fully blinded to group allocation.

Sample Size Determination:

The sample size estimation was determined using Hamidiye Ethics Committee Biostatistics Guidelines and relevant literature referencing pain reduction (McGill Pain Questionnaire) with an effect size of Cohen's d = 1.26. Given the comparison of two active interventions, an anticipated large effect size of d = 1.0 was selected. Setting alpha at 0.05 and statistical power at 80% yielded a minimum required sample of 33 participants. To ensure equal distribution across groups and accommodate potential dropouts, the target sample was finalized at 36 participants.

Intervention Protocol:

Both interventions are delivered online under the live supervision of an experienced physiotherapist and certified Qigong instructor over 12 consecutive weeks (2 sessions per week, 45 minutes per session). Each session comprises 5 minutes of structured warm-up and participant check-in, followed by 40 minutes of protocol-specific Qigong exercises. Group 1 performs dynamic, flowing movements focusing on active multi-segmental joint mobility, muscle lengthening, and breath coordination. Group 2 focuses on sustained isometric postures, focused breath regulation, and static stretching to build postural stability and endurance. Participants who miss a live session are provided structured home-practice guidance; an adherence rate of at least 90% is required for per-protocol analysis.

Assessment Protocol and Settings:

Face-to-face outcome evaluations are carried out at baseline (prior to session 1) and post-intervention at the Akdeniz University Department of Physical Medicine and Rehabilitation in a standardized, climate-controlled setting. Each assessment requires approximately 45 minutes per subject.

  • Primary Clinical Endpoints: Pain intensity and characteristics are quantified using the Short-Form McGill Pain Questionnaire (SF-MPQ, sensory and affective subscales) and a 100-mm Visual Analog Scale (VAS). Spinal mobility across cervical, thoracic, and lumbar segments (flexion, extension, lateral flexion) is measured objectively using an inclinometer.
  • Secondary Clinical Endpoints: Functional exercise capacity is measured using the submaximal 6-Minute Walk Test (6MWT) performed strictly according to 2022 American Thoracic Society (ATS) technical standards. Fatigue severity is assessed via the 9-item Fatigue Severity Scale (FSS), and overall disease-specific functional impact is measured with the Revised Fibromyalgia Impact Questionnaire (FIQR).
Conditions
Fibromyalgia
Being tested
Mobility-Intensive Qigong Exercise, Static Posture-Based Qigong Exercise
Medical subject headings
Fibromyalgia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mobility-Intensive Qigong ExerciseOther

    Dynamic and fluid mobility-intensive Qigong exercises focusing on active range of motion, muscle flexibility, muscle strengthening, and breath coordination under online physiotherapist supervision (12 weeks, 2 sessions/week, 45 minutes/session).

  • Static Posture-Based Qigong ExerciseOther

    Participants receive static posture-based Qigong exercises consisting of sustained isometric postures, breath regulation, and alignment control to enhance postural stability, static endurance, and core strengthening under online physiotherapist supervision (12 weeks, 2 sessions/week, 45 minutes/session).

Study groups in NCT07830186
Study groupRoleWhat they receive
Group 1: Mobility-Intensive QigongExperimentalParticipants receive dynamic and fluid mobility-intensive Qigong exercises focusing on active range of motion, muscle flexibility, muscle strengthening, and breath coordination under online physiotherapist supervision (12 weeks, 2 sessions/week, 45 minutes/session).
Receives: Other: Mobility-Intensive Qigong Exercise
Static Posture-Based QigongActive comparatorParticipants receive static posture-based Qigong exercises consisting of sustained isometric postures, breath regulation, and alignment control to enhance postural stability, static endurance, and core strengthening under online physiotherapist supervision (12 weeks, 2 sessions/week, 45 minutes/session).
Receives: Other: Static Posture-Based Qigong Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Pain Intensity Measured by Visual Analog Scale (VAS)

    Pain intensity is evaluated using a 100-mm Visual Analog Scale (VAS), where 0 mm indicates "no pain" and 100 mm indicates "unbearable pain." Participants mark their perceived pain intensity on a horizontal 100-mm line. Higher scores represent greater pain severity. Changes from baseline to the end of the 12-week intervention are assessed.

    Measured: Baseline and post-intervention at Week 12

Secondary outcomes (5)
  1. Change in Pain Dimensions Assessed by Short-Form McGill Pain Questionnaire (SF-MPQ)

    Qualitative and sensory/affective pain dimensions are evaluated using the Short-Form McGill Pain Questionnaire (SF-MPQ). It consists of 15 descriptors (11 sensory, 4 affective) scored on a 4-point intensity scale (0 = none, 1 = mild, 2 = moderate, 3 = severe). The total score ranges from 0 to 45. Higher scores indicate greater pain severity. Changes from baseline to Week 12 are assessed.

    Measured: Baseline and post-intervention at Week 12

  2. Change in Spinal Mobility Measured by Inclinometer

    Spinal range of motion is evaluated objectively across cervical, thoracic, and lumbar segments (flexion, extension, and lateral flexion) using a digital/bubble inclinometer. Measurements are recorded in degrees (°). Higher values indicate greater range of motion and improved spinal mobility. Changes from baseline to Week 12 post-intervention are assessed.

    Measured: Baseline and post-intervention at Week 12

  3. Change in Fatigue Severity Assessed by Fatigue Severity Scale (FSS)

    Fatigue severity and its impact on daily activities are evaluated using the 9-item self-report Fatigue Severity Scale (FSS). Items are rated on a 7-point Likert scale from 1 (strongly disagree) to 7 (strongly agree). The total score represents the mean of all items (range: 1 to 7). Higher scores indicate more severe fatigue. Changes from baseline to Week 12 are assessed.

    Measured: Baseline and post-intervention at Week 12

  4. Change in Disease Impact and Quality of Life Measured by Revised Fibromyalgia Impact Questionnaire (FIQR)

    Disease severity, symptom impact, and health-related quality of life are assessed using the Revised Fibromyalgia Impact Questionnaire (FIQR). The questionnaire comprises 21 questions across three domains (function, overall impact, symptoms) scored on an 11-point numeric scale (0 to 10). The total score ranges from 0 to 100, where higher scores reflect greater disease burden and poorer quality of life. Changes from baseline to Week 12 are assessed.

    Measured: Baseline and post-intervention at Week 12

  5. Change in Functional Exercise Capacity Assessed by 6-Minute Walk Test (6MWT)

    Submaximal functional exercise capacity is assessed using the 6-Minute Walk Test (6MWT) administered in accordance with the 2022 American Thoracic Society (ATS) technical standards. The total distance walked in meters during 6 minutes is recorded. A longer distance indicates better functional physical capacity. Changes from baseline to Week 12 are assessed.

    Measured: Baseline and post-intervention at Week 12

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2026
  2. Study start15 Oct 2026 (estimated)
  3. Primary completion21 Jan 2027 (estimated)
  4. Study completion21 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A two-arm parallel randomized controlled trial comparing mobility-intensive Qigong against static posture-based Qigong.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
36 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07830186
Sponsor's protocol ID
SBU-AKSARIGEDIKLI-001
Status last verified
Sep 2026
First submitted
15 Sep 2026
Last updated
24 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared in order to protect participant confidentiality and comply with local ethical committee guidelines and personal data protection regulations.

Questions about this trial

What is this clinical trial studying?

A study testing Mobility-Intensive Qigong Exercise and Static Posture-Based Qigong Exercise in people with Fibromyalgia, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 24 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact MERYEM AKSARI GEDİKLİ, PT, MSc, PhD(c) (+90 531 208 15 15, aksarimeryem@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Pain Intensity Measured by Visual Analog Scale (VAS) (time frame: Baseline and post-intervention at Week 12). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in